Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syntaxin-4 is a plasma membrane t-SNARE protein critical for the docking and fusion of transport vesicles during vesicle-mediated exocytosis[1]. It is essential for processes such as the translocation of glucose transporter SLC2A4 (GLUT4) to the plasma membrane in response to insulin, contributing to glucose homeostasis, and is found in neurons, where it regulates postsynaptic membrane trafficking and is required for synaptic plasticity (including long-term potentiation)[2]. Syntaxin-4 is widely expressed with key roles in neurons, adipocytes, and epithelial cells, and its dysfunction is associated with autosomal recessive nonsyndromic deafness and potentially with some cancers (as a renal carcinoma antigen)[1][2][5].
Mediates SNARE complex formation for vesicle fusion and exocytosis Is essential for trafficking of specific membrane proteins (e.g., GLUT4 in adipocytes, dopamine transporter in neurons)[1][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syntaxin-4 (STX4).